Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

36,775.00ZAc
29 Jun 2015
Change (% chg)

-- (--)
Prev Close
36,775.00c
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,237,215
52-wk High
44,868.00c
52-wk Low
28,006.00c

APNJ.J

Chart for APNJ.J

About

Aspen Pharmacare Holdings Limited is a South Africa-based pharmaceutical company. The Company through its subsidiaries manufactures branded and generic pharmaceutical products as well as infant milk nutritionals and consumer healthcare products in selected territories, operating primarily in the healthcare industry. The Company... (more)

Overall

Beta: 0.36
Market Cap(Mil.): R171,126.09
Shares Outstanding(Mil.): 456.35
Dividend: 188.00
Yield (%): 0.50

Financials

  APNJ.J Industry Sector
P/E (TTM): 30.90 35.71 39.60
EPS (TTM): 12.13 -- --
ROI: 8.38 17.04 16.23
ROE: 19.81 17.93 17.37
Search Stocks

UPDATE 1-India's Strides to buy Australia, Mauritius drug assets from Aspen for $300 mln

MUMBAI, May 21 - Indian drugmaker Strides Arcolab Ltd has agreed to buy businesses in Australia and Mauritius from South Africa's Aspen Pharmacare Holdings Ltd , paying $300 million to expand its footprint in markets set for brisk growth.

21 May 2015

India's Strides Arcolab to buy some Australia drug assets from Aspen Pharmacare

MUMBAI, May 21 - Indian drugmaker Strides Arcolab Ltd said on Thursday it has agreed to buy a generic drugs business in Australia from South Africa's Aspen Pharmacare Holdings Ltd for about A$380 million ($299.90 million).

21 May 2015

BRIEF-Aspen Pharmacare divests branded, generic products portfolio to Strides Pharma entities

* Aspen Global incorporated has entered into agreement with Strides Singapore for a consideration of about $92 million

21 May 2015

BRIEF-Aspen Pharmacare says in talks for possible acquisition of infant nutritionals business

* Is currently engaged in discussions regarding a possible acquisition of an infant nutritionals business Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

14 May 2015

BRIEF-Aspen Pharmacare sells a South African unit for about 1.6 bln rand

* Says deal for a consideration of approximately R1.6 billion

11 May 2015

GSK raises $853 million by halving stake in South African drugmaker

LONDON - GlaxoSmithKline has taken profits in Aspen Pharmacare by selling half its stake in the South African drugmaker for $853 million, following a long investment in the firm.

13 Mar 2015

BRIEF-GSK raises $853 mln via partial sale of Aspen Pharmacare shares

* GSK completes partial sale of Aspen Pharmacare Holdings Ltd shares - LSE announcement

13 Mar 2015

GSK to pocket $890 million by halving stake in South African drugmaker

LONDON - GlaxoSmithKline has decided to take profits in Aspen Pharmacare by halving its stake in the South African drugmaker, following a long investment in the firm.

12 Mar 2015

UPDATE 1-GSK to pocket $890 mln by halving stake in S.African drugmaker

LONDON, March 12 - GlaxoSmithKline has decided to take profits in Aspen Pharmacare by halving its stake in the South African drugmaker, following a long investment in the firm.

12 Mar 2015

GSK launches $890mln placement in Aspen Pharmacare - source

LONDON, March 12 - GlaxoSmithKline has launched a $890 million share sale in South African drug company Aspen Pharmacare, a source familiar with the matter said on Thursday.

12 Mar 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$10.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks